Lack of evidence raises questions on long-term PPI use

There is rising concern over the side effects of long-term proton pump inhibitor (PPI) use but limited evidence to warrant discontinuation, a literature review...

Medicine misadventure is common, reveals PSA

The Pharmaceutical Society of Australia (PSA) has released a new report, Medicine Safety: Take Care, which highlights the extent of the unsafe use of...

PSA: embed pharmacists to reduce medicine harm in aged care

PSA has called for a national program that embeds pharmacists in all aged care facilities in its submission to the Royal Commission into Aged...

Patrick Reid extended interview

I've been lobbying pretty hard for a long time as both a pharmacist and the CEO of a large aged-care provider for pharmacists to...

Pain pointers: How to prepare your pharmacy for codeine change

Preparing now for the up‑scheduling of codeine‑containing medicines to prescription-only will mean pharmacists are in a better position to inform and educate their customers....

Royal Pharmaceutical Society director on the future of pharmacy

Ravi Sharma’s credentials in pharmacy are formidable. Recently appointed the Royal Pharmaceutical Society’s (RPS’s) director for England, he was also National Clinical Lead for...